Cargando…
Antivenoms for Snakebite Envenoming: What Is in the Research Pipeline?
Autores principales: | Alirol, Emilie, Lechevalier, Pauline, Zamatto, Federica, Chappuis, François, Alcoba, Gabriel, Potet, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565558/ https://www.ncbi.nlm.nih.gov/pubmed/26355744 http://dx.doi.org/10.1371/journal.pntd.0003896 |
Ejemplares similares
-
Understanding and tackling snakebite envenoming with transdisciplinary research
por: Gutiérrez, José María, et al.
Publicado: (2022) -
Snakebite envenoming at MSF: A decade of clinical challenges and antivenom access issues
por: Potet, Julien, et al.
Publicado: (2022) -
Acute Severe Anaphylaxis in Nepali Patients with Neurotoxic Snakebite Envenoming Treated with the VINS Polyvalent Antivenom
por: Sharma, Sanjib Kumar, et al.
Publicado: (2019) -
Dose of antivenom for the treatment of snakebite with neurotoxic envenoming: Evidence from a randomised controlled trial in Nepal
por: Alirol, Emilie, et al.
Publicado: (2017) -
Availability, accessibility and use of antivenom for snakebite envenomation in Africa with proposed strategies to overcome the limitations
por: Dalhat, Mahmood Muazu, et al.
Publicado: (2023)